Clinical Research Therapist

Conduct Preparation, dosing and integration sessions as part of clinical trials.

2023:  Lead Research Therapist – 100 hours of supervised training in Psilocybin therapy for treatment resistant depression – COMPASS Study: A phase III, multicentre, randomised, double-blind, placebo- controlled study to investigate the efficacy, safety, and tolerability of a single administration of COMP360 in participants with treatment-resistant depression [COMP-005]

2023   Lead Research Therapist – 30 hours of Training. A 24 week, multi Centre, randomized, double blind, placebo controlled, parallel-group, PHASE 2 Clinical Trial to evaluate efficacy and safety of psilocybin-assisted psychotherapy in adults with alcohol use disorder (AUD)

I currently work with Psilicybin & MDMA for PTSD, depression, and substance misuse. Reach out for more information